Latest Drug Approvals news
Time From Drug Approval to Reimbursement Longer in U.S. Than Some European Countries
posted September 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Voranigo for Grade 2 Astrocytoma or Oligodendroglioma
posted August 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Laser Interstitial Thermal Therapy Beneficial for Brain Tumors 
Stereotactic Radiation Improves Brain Metastases Symptoms, Interference With Daily Functioning 
Colorectal Cancer Risen to Leading Cause of Cancer Death in Men Under 50 
Eflornithine + Lomustine Beneficial for Recurrent Grade 3 Astrocytoma Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
